AFG3L2 and color vision disorder: Similar to patients with DOA caused by mutations in the ATPase domain of AFG3L2 and other genes, our patients also developed the disease in childhood, presenting with decreased visual acuity, impaired visual field, color vision disorder, pale optic disc, and thinning of RNFL.